It is vital for life sciences companies to understand evolving industry best practices in the current CME environment. Government scrutiny of grants by life sciences companies remains at an all-time high. Recent settlements reveal that prosecutors continue to treat certain grants as a mechanism to promote off-label uses of products.
We counsel life sciences companies on how best to approach evaluation of grant opportunities and develop steps to ensure compliance with:
For CME programs, we track changes to the Standards for Commercial Support and guidances of the Accreditation Council for Continuing Medical Education. This knowledge enables us to evaluate a company’s compliance with these ACCME standards. We also counsel on CME guidelines:
To help life sciences companies minimize legal risks associated with their valuable and increasingly high-risk endeavors, Porzio develops policies and procedures, and conducts training to guide business personnel. In addition, we:
We are committed to keeping you at the forefront of changes affecting CME support and grants.